FDA Hits Guardian Drug for Lack of Quality Controls, Secure Data Post author:Sam Post published:April 11, 2017 Post category:Drug Industry Daily The FDA cited Guardian Drug Company over quality and data storage issues. Source: Drug Industry Daily You Might Also Like Compounding Pharmacy Draws Warning Letter for Misbranded, Unapproved Drugs January 24, 2017 Leqembi Wins Full Approval and Market Edge With Medicare Coverage July 7, 2023 FDA Calls for Long-Term Safety Studies in Neonatal Product Development February 9, 2023